Peel Hunt Reaffirms “Add” Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “add” rating reaffirmed by Peel Hunt in a note issued to investors on Tuesday, MarketBeat.com reports. They presently have a GBX 280 ($3.71) price target on the stock. Peel Hunt’s price objective would suggest a potential upside of 21.21% from the stock’s current price.

Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 307 ($4.07) target price on shares of ConvaTec Group in a report on Wednesday, July 9th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 315 ($4.18) price objective on shares of ConvaTec Group in a research note on Thursday, July 3rd. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of GBX 303.40 ($4.02).

ConvaTec Group Price Performance

LON CTEC opened at GBX 231 ($3.06) on Tuesday. The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The stock has a market cap of £5.87 billion, a price-to-earnings ratio of 38.90, a PEG ratio of 0.93 and a beta of 0.64. The business has a 50 day simple moving average of GBX 272.98 and a 200 day simple moving average of GBX 259.22. ConvaTec Group has a 52-week low of GBX 211.80 ($2.81) and a 52-week high of GBX 311.20 ($4.13).

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.